Soleus Capital Management’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.85M | Hold |
2,262,026
|
|
||||
|
2025
Q1 | $3.57M | Hold |
2,262,026
|
|
||||
|
2024
Q4 | $4.05M | Sell |
2,262,026
-2,026,141
|
|
||||
|
2024
Q3 | $26M | Buy |
4,288,167
+77,630
|
|
||||
|
2024
Q2 | $22.1M | Buy |
4,210,537
+620,979
|
|
||||
|
2024
Q1 | $30.5M | Sell |
3,589,558
-738,064
|
|
||||
|
2023
Q4 | $28.6M | Buy |
4,327,622
+40,528
|
|
||||
|
2023
Q3 | $13.2M | Buy |
4,287,094
+85,000
|
|
||||
|
2023
Q2 | $11.3M | Buy |
4,202,094
+56,977
|
|
||||
|
2023
Q1 | $12.3M | Buy |
4,145,117
+275,725
|
|
||||
|
2022
Q4 | $9.75M | Buy |
3,869,392
+1,228,853
|
|
||||
|
2022
Q3 | $4.81M | Sell |
2,640,539
-1,528,260
|
|
||||
|
2022
Q2 | $13.1M | Sell |
4,168,799
-55,000
|
|
||||
|
2022
Q1 | $26.1M | Buy |
4,223,799
+698,342
|
|
||||
|
2021
Q4 | $50.1M | Buy |
3,525,457
+657,434
|
|
||||
|
2021
Q3 | $22.9M | Buy |
2,868,023
+629,919
|
|
||||
|
2021
Q2 | $63.9M | Buy |
2,238,104
+168,052
|
|
||||
|
2021
Q1 | $60.1M | Sell |
2,070,052
-305,629
|
|
||||
|
2020
Q4 | $28.3M | Buy |
2,375,681
+548,701
|
|
||||
|
2020
Q3 | $12.6M | Sell |
1,826,980
-255,205
|
|
||||
|
2020
Q2 | $12.9M | Buy |
2,082,185
+1,764
|
|
||||
|
2020
Q1 | $8.32M | Buy |
2,080,421
+446,052
|
|
||||
|
2019
Q4 | $8.99M | Buy |
+1,634,369
|
|